NEXENTIS TECHNOLOGIES INC. Accounts Payable, Other, Current
NEXENTIS TECHNOLOGIES INC. (NXTS) had Accounts Payable, Other, Current of $383.55 thousand as of 2021-12-31, per its 10-K filed 2022-03-31.
Discontinued › Notes › Payables and Accruals
us-gaap:AccountsPayableOtherCurrent · last filed 2022-03-31
- 2021-12-31: Accounts Payable, Other, Current $383.55K.
- 2020-12-31: Accounts Payable, Other, Current $517.71K.
- 2020-09-30: Accounts Payable, Other, Current $455.68K.
- 2020-06-30: Accounts Payable, Other, Current $419.37K.
| Period end | Accounts Payable, Other, Current |
|---|---|
| 2021-12-31 | $383.55K 10-K · filed 2022-03-31 |
| 2020-12-31 | $517.71K 10-K · filed 2022-03-31 |
| 2020-09-30 | $455.68K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $419.37K 10-Q · filed 2020-08-11 |
| 2020-03-31 | $392.15K 10-Q · filed 2020-05-15 |
| 2019-12-31 | $380.73K 10-K · filed 2021-03-29 |
| 2018-12-31 | $264.00K 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |